Trump announces deals with Eli Lilly, Novo Nordisk to slash weight loss drug prices, offer
U.S. President Donald Trump attends an event to make an announcement from the Oval Office at the White House in
Read More
Eli
Eli Lilly to start late-stage trials on amylin obesity drug after it shows up to 20% weight
Eli Lilly Biotechnology Center is shown in San Diego, California, March 1, 2023. Mike Blake | Reuters Eli Lilly on
Read More
We’re raising our Eli Lilly price target — what a difference a quarter makes
Eli Lilly shares jumped Thursday after the drugmaker posted a strong third quarter, driven by sales of its popular GLP-1
Read More
Eli Lilly, Nvidia partner to build supercomputer, AI factory for drug discovery and
Eli Lilly and Nvidia are partnering to build what they call the pharmaceutical industry’s “most powerful” supercomputer and so-called AI
Read More
Eli Lilly to build $6.5 billion Texas manufacturing facility for obesity pill, other drugs
A rendering of Eli Lilly’s manufacturing facility in Houston, Texas. Courtesy: Eli Lilly Eli Lilly on Tuesday said it will
Read More
Eli Lilly pill outperforms Novo Nordisk’s oral drug in head-to-head diabetes trial
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024.
Read More
Eli Lilly to build $5 billion Virginia facility to boost production of targeted cancer
Eli Lilly Biotechnology Center is shown in San Diego, California, March 1, 2023. Mike Blake | Reuters Eli Lilly on
Read More
Eli Lilly, Novo Nordisk prepare to face off in the next obesity drug battleground
Eli Lilly and Novo Nordisk are preparing to take their rivalry to the next frontier of weight-loss medications: pills. Both
Read More
Eli Lilly’s weight loss pill succeeds in first late-stage trial on diabetes patients; shares
Eli Lilly on Thursday said its daily obesity pill met the company’s goals in the first of several late-stage trials,
Read More
Stocks making the biggest moves midday: Eli Lilly, Alphabet, Hertz, UnitedHealth and more
Check out the companies making headlines in midday trading: Alphabet — Shares of the megacap technology name pulled back 1.4%
Read More